Literature DB >> 16091205

WHIM syndrome: a defect in CXCR4 signaling.

George A Diaz1, A Virginia Gulino.   

Abstract

The study of inherited immunodeficiencies has proven valuable in elucidating molecular signaling cascades underlying the developmental and functional regulation of the human immune system. The first example of a human immunologic disease caused by mutation of a chemokine receptor was provided by WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome, a rare, combined immunodeficiency featuring an unusual form of neutropenia. Subsequent studies following the initial description of mutations in the CXCR4 gene have revealed a striking concordance in the types of mutations observed, suggesting that impaired regulation of receptor signaling by truncation of the cytoplasmic tail domain is an essential aspect in disease pathogenesis. Biochemical studies have provided support for the model that impaired receptor downregulation leads to the characteristic immunologic and hematologic disturbances. Interestingly, these genetic studies have also identified phenocopies with the same clinical features but without mutation of CXCR4, suggesting that mutations in as yet uncharacterized downstream regulators of the receptor may be involved in a proportion of cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091205     DOI: 10.1007/s11882-005-0005-0

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  40 in total

1.  Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence.

Authors:  Coralie Martin; Peter C E Burdon; Gary Bridger; Jose Carlos Gutierrez-Ramos; Timothy J Williams; Sara M Rankin
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

2.  Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis.

Authors:  Benjamin T Suratt; Joseph M Petty; Scott K Young; Kenneth C Malcolm; Jonathan G Lieber; Jerry A Nick; Jose-Angel Gonzalo; Peter M Henson; G Scott Worthen
Journal:  Blood       Date:  2004-03-30       Impact factor: 22.113

Review 3.  A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia.

Authors:  M Wetzler; M Talpaz; E S Kleinerman; A King; Y O Huh; J U Gutterman; R Kurzrock
Journal:  Am J Med       Date:  1990-11       Impact factor: 4.965

4.  Identification of a major co-receptor for primary isolates of HIV-1.

Authors:  H Deng; R Liu; W Ellmeier; S Choe; D Unutmaz; M Burkhart; P Di Marzio; S Marmon; R E Sutton; C M Hill; C B Davis; S C Peiper; T J Schall; D R Littman; N R Landau
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

5.  An unusual form of chronic neutropenia in a father and daughter with hypogammaglobulinaemia.

Authors:  W C Mentzer; R B Johnston; R L Baehner; D G Nathan
Journal:  Br J Haematol       Date:  1977-07       Impact factor: 6.998

6.  Myelokathexis associated with multiple congenital malformations: immunological study on phagocytic cells and lymphocytes.

Authors:  A Plebani; A Cantù-Rajnoldi; G Collo; P Allavena; A Biolchini; A Pirelli; M Clerici Schoeller; M Masarone
Journal:  Eur J Haematol       Date:  1988-01       Impact factor: 2.997

7.  Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors.

Authors:  A A Aprikyan; W C Liles; J R Park; M Jonas; E Y Chi; D C Dale
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

8.  Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome. Warts, hypogammaglobulinemia, infections, and myelokathexis.

Authors:  S Imashuku; A Miyagawa; T Chiyonobu; H Ishida; T Yoshihara; T Teramura; K Kuriyama; T Imamura; S Hibi; A Morimoto; S Todo
Journal:  Ann Hematol       Date:  2002-07-20       Impact factor: 3.673

9.  Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.

Authors:  Paolo A Hernandez; Robert J Gorlin; John N Lukens; Shoichiro Taniuchi; Joze Bohinjec; Fleur Francois; Mary E Klotman; George A Diaz
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

10.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

View more
  20 in total

Review 1.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

2.  Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin.

Authors:  James W Murphy; Yoonsang Cho; Aristidis Sachpatzidis; Chengpeng Fan; Michael E Hodsdon; Elias Lolis
Journal:  J Biol Chem       Date:  2007-01-29       Impact factor: 5.157

3.  CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions.

Authors:  Kyle J Eash; Jacquelyn M Means; Douglas W White; Daniel C Link
Journal:  Blood       Date:  2009-03-05       Impact factor: 22.113

4.  The E3 ubiquitin ligase atrophin interacting protein 4 binds directly to the chemokine receptor CXCR4 via a novel WW domain-mediated interaction.

Authors:  Deepali Bhandari; Seth L Robia; Adriano Marchese
Journal:  Mol Biol Cell       Date:  2008-12-30       Impact factor: 4.138

5.  A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome.

Authors:  Alessandra Handisurya; Christina Schellenbacher; Bärbel Reininger; Frieder Koszik; Philipp Vyhnanek; Andreas Heitger; Reinhard Kirnbauer; Elisabeth Förster-Waldl
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

Review 6.  Neutrophil migration under normal and sepsis conditions.

Authors:  Yelena V Lerman; Minsoo Kim
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2015

Review 7.  Genetics on a WHIM.

Authors:  Omar Al Ustwani; Razelle Kurzrock; Meir Wetzler
Journal:  Br J Haematol       Date:  2013-09-20       Impact factor: 6.998

8.  G Protein-Coupled Receptor Kinase 3 and Protein Kinase C Phosphorylate the Distal C-Terminal Tail of the Chemokine Receptor CXCR4 and Mediate Recruitment of β-Arrestin.

Authors:  Jiansong Luo; John M Busillo; Ralf Stumm; Jeffrey L Benovic
Journal:  Mol Pharmacol       Date:  2017-03-22       Impact factor: 4.436

9.  Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.

Authors:  B Mark Woerner; Jingqin Luo; Kristin R Brown; Erin Jackson; Sonika M Dahiya; Paul Mischel; Jeffrey L Benovic; David Piwnica-Worms; Joshua B Rubin
Journal:  Mol Cancer Res       Date:  2011-11-15       Impact factor: 5.852

10.  CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation.

Authors:  Alex J Carlisle; Christopher A Lyttle; Rosalind Y Carlisle; John M Maris
Journal:  Mol Cancer       Date:  2009-12-22       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.